Ann: Q&A on the merger of QBL MCL and Medcan, page-507

Hi @Tomasp

"Additionally, if dividends are being paid, the same amount of dividend is now divided by double number of shares (essentially halving the dividend per share payment). So post-dilution you would be receiving half the payment you would receive pre-dilution."

Won't the profit pool for dividends now be 45% greater to be divided by roughly 45% more shares on issue?

Totally agree that we will be at a disadvantage in regards to any potential profits from Bauxite deals in the future, question again is do shareholders feel this is offset by the benefits from owning 100% of MCL.

We do currently have a controling stake in MCL however despite this many posters expressed fear of an MCL IPO, I personally didn't belieeve QBL management would allow this to happen.

It felt to me posters & probably the market where calling for a consolidation of the two companies moving forward.

Let's see what comes out of the shareholders meeting.

I agree with @elite that a presentation by management will assist shareholders understandings of the proposed aquisitions & any advantages we stand to gain.

Thanks,